Texas Prostate hits 100th TULSA Procedure; volumes up 500% under new Medicare model

Profound Medical Corp.

Texas Prostate, led by Dr. James Cochran, performed its 100th TULSA Procedure at Dallas Medical Center.
Procedure volumes increased 500% after transitioning from private pay to a Medicare model via Dallas Medical Center.
Dr. Cochran cited TULSA's MRI-guidance and thermography for broader treatment range and improved safety versus HIFU.
CEO Arun Menawat said the model demonstrates a path for accelerating TULSA adoption across prostate care.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.